A pharmaceutical executive sprinted half a block to a home with a red door when questioned about fetal cells in her company’s Covid-19 vaccine.
Project Veritas released a video of an encounter between one of their reporters and a woman they identify as Pfizer’s Senior Director of Worldwide Research, Development and Medical Communications, Vanessa Gelman.
The questioning stemmed from a broadcast interview between a Project Veritas reporter and Pfizer whistleblower Melissa Strickler that showed company emails between Ms. Gelman and other company officials. The emails discussed the use of fetal cell tissue use in the Pfizer Covid-19 vaccines.
One email highlighted in the interview is from Pfizer Senior Director Advait Badkar, asking if the company made use of aborted fetal cell tissue during vaccine testing. Gelman asked Badkar who wanted to know, adding the company has been trying as much as possible not to mention the fetal cell use.
“One or more cell lines with an origin that can be traced back to human fetal tissue has been used in laboratory tests associated with the vaccine program,” Gelman told Badkar.
Philip Dormitzer is Pfizer’s Chief Scientific Officer for Viral Vaccines. Dormitzer admitted to Badkar the company used cells from an aborted fetus in an email shared by Strickler.
“HEK293T cells, used for the IVE assay, are ultimately derived from an aborted fetus,” Dormitzer told Badkar, adding the company has an approved answer for questions about fetal cell use, which Gelman could provide.
“From the perspective of corporate affairs, we want to avoid having the information on fetal cells floating out there,” Gelman said in another email to a number of company employees. “The risk of communicating this right now outweighs any potential benefit we could see, particularly with general members of the public who may take this information and use it in ways we may not want out there.”
Gelman noted the pharmaceutical giant had not been questioned by policymakers or media about the cell tissue issue, adding the company wanted to avoid raising the subject, if possible.
Gelman was not reachable for comment. Her Twitter account, @vanessagelman, has been deactivated and her LinkedIn profile has been deleted. A search for her name on Pfizer’s website did not return any results for her, nor was her bio among the many medical professionals profiled on their site.
Scroll down to leave a comment and share your thoughts.